Teladoc Health (NYSE:TDOC – Get Rating) had its price objective lowered by Deutsche Bank Aktiengesellschaft from $34.00 to $31.00 in a report issued on Tuesday morning, The Fly reports. The firm currently has a hold rating on the health services provider's stock.

A number of other brokerages also recently commented on TDOC. Oppenheimer decreased their price target on Teladoc Health from $65.00 to $55.00 and set an outperform rating for the company in a research report on Thursday, July 28th. StockNews.com raised Teladoc Health to a sell rating in a research report on Tuesday, August 9th. KeyCorp initiated coverage on Teladoc Health in a research report on Thursday, September 15th. They issued a sector weight rating for the company. Cowen lowered Teladoc Health from an outperform rating to a market perform rating and cut their price target for the stock from $58.00 to $34.00 in a report on Tuesday, August 2nd. Finally, Needham & Company LLC lowered Teladoc Health from a buy rating to a hold rating in a report on Thursday, July 28th. Two research analysts have rated the stock with a sell rating, twenty-four have issued a hold rating and five have given a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of Hold and an average price target of $64.13.

Teladoc Health Stock Down 3.4 %

Shares of NYSE:TDOC opened at $25.35 on Tuesday. The firm has a market cap of $4.09 billion, a P/E ratio of -0.41 and a beta of 0.86. Teladoc Health has a 52-week low of $25.33 and a 52-week high of $156.82. The business's 50 day simple moving average is $33.43 and its two-hundred day simple moving average is $41.47. The company has a debt-to-equity ratio of 0.25, a quick ratio of 3.22 and a current ratio of 3.38.

Insider Buying and Selling at Teladoc Health

In other Teladoc Health news, insider Arnnon Geshuri sold 4,098 shares of Teladoc Health stock in a transaction that occurred on Friday, August 26th. The stock was sold at an average price of $34.27, for a total transaction of $140,438.46. Following the sale, the insider now directly owns 76,182 shares of the company's stock, valued at approximately $2,610,757.14. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other news, SVP Daniel Trencher sold 1,000 shares of the business's stock in a transaction that occurred on Wednesday, August 17th. The stock was sold at an average price of $37.50, for a total value of $37,500.00. Following the sale, the senior vice president now directly owns 26,408 shares of the company's stock, valued at approximately $990,300. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, insider Arnnon Geshuri sold 4,098 shares of the business's stock in a transaction that occurred on Friday, August 26th. The stock was sold at an average price of $34.27, for a total value of $140,438.46. Following the completion of the sale, the insider now directly owns 76,182 shares in the company, valued at $2,610,757.14. The disclosure for this sale can be found here. In the last three months, insiders have sold 7,318 shares of company stock valued at $255,321. 1.55% of the stock is currently owned by corporate insiders.

Institutional Trading of Teladoc Health

A number of hedge funds have recently made changes to their positions in the stock. Royal London Asset Management Ltd. lifted its position in Teladoc Health by 2.9% in the 2nd quarter. Royal London Asset Management Ltd. now owns 53,551 shares of the health services provider's stock valued at $1,779,000 after acquiring an additional 1,502 shares in the last quarter. Captrust Financial Advisors lifted its position in Teladoc Health by 38.7% in the 2nd quarter. Captrust Financial Advisors now owns 6,746 shares of the health services provider's stock valued at $224,000 after acquiring an additional 1,882 shares in the last quarter. Legal & General Group Plc lifted its position in Teladoc Health by 0.7% in the 2nd quarter. Legal & General Group Plc now owns 946,027 shares of the health services provider's stock valued at $31,418,000 after acquiring an additional 6,478 shares in the last quarter. ExodusPoint Capital Management LP lifted its position in Teladoc Health by 146.6% in the 2nd quarter. ExodusPoint Capital Management LP now owns 36,634 shares of the health services provider's stock valued at $1,217,000 after acquiring an additional 21,777 shares in the last quarter. Finally, Quantum Private Wealth LLC increased its stake in shares of Teladoc Health by 3.4% in the 2nd quarter. Quantum Private Wealth LLC now owns 11,614 shares of the health services provider's stock worth $385,000 after purchasing an additional 379 shares in the last quarter. 92.46% of the stock is owned by institutional investors.

Teladoc Health Company Profile

(Get Rating)

Teladoc Health, Inc provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions.

See Also

• Get a free copy of the StockNews.com research report on Teladoc Health (TDOC)
• EV Battery Maker Freyr Set For Major Global Expansion
• MarketBeat: Week in Review 9/26 – 9/30
• This Is A Memorable Time To Buy Into Micron Technology
• Thor Industries Hammers Out A Bottom
• Let Paychex Stock Work Hard For You

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.